Skip to main content

Table 3 Sensitivity for detection of methylated TRIM9 in plasma of Stage IV and metastatic breast cancer patients

From: Promoter methylation of TRIM9 as a marker for detection of circulating tumor DNA in breast cancer patients

 

Total

Methylated TRIM9 in plasma

 

Positive

Negative

No.

(%)

No.

(%)

Healthy control

60

0

(0)

60

(100)

MBC patients (total)

56

10

(18)

46

(82)

MBC patients with TRIM9 hypermethylated tumors

9

4

(44)

5

(56)

MBC patients with TRIM9 hypomethylated tumors

18

1

(6)

17

(94)

  1. MBC metastatic breast cancer